Jounce Therapeutics Inc. (JNCE) Dipped -6.78% or -1.63 To Price $22.42 On Tuesday


Jounce Therapeutics Inc. (JNCE) dipped -6.78% or -1.63 to $22.42. It is nearly 324524 shares traded, which is 95.79% compare to the average total volume 338777. The market cap of JNCE is $722.95 million. The year to date change is 79.48%. The 52 week price range is from $11.05 to $29.29. Price of JNCE have changed 3.49% during last week. It have changed 10.52% over last month, 59.91% over last 3 months, 67.71% over last 6 months and 17.78% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for JNCE is 18.21. It is -18.78% below current price. The 200-day Moving Averages for JNCE is 16.70. It is -25.51% below current price. The 52-week High is 29.29. It is 30.64% from the current price. The 52-week Low is 11.05. It is -50.71% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of JNCE is 11.47 on 2018-01-31. Short % to float is 12.19%. There are some statistics of JNCE. It is has market cap $722.95 million. The share outstanding is 32.25 million. The average volume is 338777. The revenue is 78.94M. The percent of top 15 Institution holding is 51.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of JNCE is -4.31%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of JNCE is -1.71%.


Tags:

Share this post